ArticleInternational journal of clinical pharmacy2022

A novel rituximab administration protocol to minimize infusion-related adverse reactions in patients with B-cell lymphoma.

Daisuke Tsutsumi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.